A carregar...

Fenofibrate Therapy in Carnitine Palmitoyl Transferase Type 2 Deficiency

Bezafibrate therapy has been shown to improve beta-oxidation of fatty acids and to reduce episodes of rhabdomyolysis in patients with carnitine palmitoyltransferase type-2 (CPT2) deficiency. We report the efficacy of fenofibrate in a patient with CPT2 deficiency, in whom beta-oxidation was improved...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hamilton-Craig, I., Yudi, M., Johnson, L., Jayasinghe, R.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3521633/
https://ncbi.nlm.nih.gov/pubmed/23326270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/163173
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!